Customer Q&A: Novartis

Novartis has a rich history of investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. As the industry faces acute disruption, the company’s prescription for ongoing success hinges on APIs and microservices. Pascal Bouquet, Global Head of Architecture for Drug Development, answers a few questions about how digital transformation is moving Novartis forward.  

Previous Asset
Engie creates a data-driven, API-first enterprise
Engie creates a data-driven, API-first enterprise

Engie accelerates development of data-driven services with faster, more secure partner collaboration.

Next Asset
Ovum Enterprise Case Study - Commerzbank: Achieving Operational Transformation Using API Management
Ovum Enterprise Case Study - Commerzbank: Achieving Operational Transformation Using API Management

How Commerzbank improved API development processes with Axway AMPLIFY™ Management